MAP PHARMACEUTICALS, INC.
🏢 View company profile →34Patents
32Active
34Granted
53Portfolio score
Filing activity: Dec 6, 2002 → Mar 28, 2017 · 9 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7994197B2 | Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile | Human Necessities | 26 | Active |
| US8119639B2 | Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile | Human Necessities | 23 | Active |
| US8604035B2 | Fluoroergoline analogs | Chemistry; Metallurgy | 19 | Active |
| US8710092B2 | Substituted indolo 4,3 FG quinolines useful for treating migraine | Chemistry; Metallurgy | 19 | Active |
| US8486043B2 | Inhalation drug delivery | Human Necessities | 19 | Active |
| US8592445B2 | Iso-ergoline derivatives | Chemistry; Metallurgy | 18 | Active |
| US8722699B2 | Iso-ergoline derivatives | Chemistry; Metallurgy | 17 | Active |
| US8895743B2 | Methysergide derivatives | Chemistry; Metallurgy | 14 | Active |
| US9012640B2 | Cabergoline derivatives | Chemistry; Metallurgy | 14 | Active |
| US8946420B2 | Neuromodulatory compounds | Human Necessities | 14 | Active |
| US8969374B2 | Iso-ergoline derivatives | Chemistry; Metallurgy | 14 | Active |
| US8933093B2 | Fluoroergoline analogs | Chemistry; Metallurgy | 14 | Active |
| US8927567B2 | Fluoroergoline analogs | Chemistry; Metallurgy | 14 | Active |
| US8841448B2 | Fluoroergoline analogs | Chemistry; Metallurgy | 14 | Active |
| US9394314B2 | 8′-hydroxy-dihydroergotamine compounds and compositions | Chemistry; Metallurgy | 13 | Active |
| US9365591B2 | Fluoroergoline analogs | Chemistry; Metallurgy | 12 | Active |
| US9150593B2 | Fluoroergoline analogs | Chemistry; Metallurgy | 12 | Active |
| US7862751B2 | Formulation of fine particles using liquefield or dense gases | Emerging Cross-Sectional Technologies | 7 | Expired |
| US8148377B2 | Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile | Human Necessities | 6 | Active |
| US9833451B2 | Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile | Human Necessities | 3 | Active |
| US9216259B2 | Methods and apparatus for delivering aerosolized medication | Human Necessities | 2 | Active |
| US8517009B2 | Methods and apparatus for delivering aerosolized medication | Human Necessities | 2 | Active |
| US9227030B2 | Enhanced eductor design | Human Necessities | 2 | Active |
| US8555875B2 | Inhalation devices and related methods for administration of sedative hypnotic compounds | Human Necessities | 2 | Active |
| US9480803B2 | Dose counter with lockout mechanism | Human Necessities | 1 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.